Keywords: USA, FDA, Johnson & Johnson, Pancreaze, Mylan, Wellbutrin, Hyzaar

US FDA approves Johnson & Johnson’s Pancreaze; clears two generics for Mylan

Article | 13 April 2010

Print This

US drug major Johnson & Johnson says that the Food and Drug Administration has approved Pancreaze Delayed Release Capsules, its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in